Introduction: The shift from conventional injections to long-acting drug delivery systems has transformed modern ophthalmic treatment. A well-designed Dexamethasone Sodium […]
How to Develop a Dexamethasone Sodium Phosphate Injection Read More »
Introduction Selecting the right partner is a critical step in generic drug development. Pharmaceutical companies must Choose Right CRO/CDMO for
How to Choose the Right CRO/CDMO for ANDA Submission Read More »
Introduction: Nitrosamine Risk Assessment in Generic Drugs is now a key scientific process used to control harmful impurities in medicines.
Nitrosamine Risk Assessment in Generic Drug Development for ANDA Submission Read More »
Introduction The comparison of Peptide vs Antibody Oligonucleotide Conjugates has become an important topic in the development of modern oligonucleotide
Comparison of POCs vs Antibody-Oligonucleotide Conjugates Read More »
Introduction: The primary therapeutic advantage of Peptide Oligonucleotide Conjugates Drug Delivery lies in its ability to enable precise, extrahepatic tissue
Drug Delivery Advantages of Peptide-Oligonucleotide Conjugates (POCs) Read More »
Introduction Peptide Oligonucleotide Conjugates Pharmacokinetics focuses on how peptide-linked nucleic acid therapeutics distribute, metabolize, and remain active in biological systems
Pharmacokinetics of Peptide-Oligonucleotide Conjugates Read More »
Introduction: Peptide-oligonucleotide conjugates (POCs) require carefully controlled strategies to remain stable because they combine two sensitive components—peptides and nucleic acids.
Stability Considerations for Peptide-Oligonucleotide Conjugates Read More »
Introduction Forced Degradation Studies for ANDA play an important role in stability assessment and impurity control during generic drug development.
Forced Degradation Studies for ANDA: Designing Stability and Impurity Pathways Read More »
Introduction In Abbreviated New Drug Applications (ANDA), ANDA Analytical Deficiencies are one of the most common reasons for delays, Complete
Common Analytical Deficiencies in ANDA Submissions (and How to Avoid Them) Read More »
Introduction: Nitrosamine risk assessment and Nitrosamine Testing in ANDA Submissions refer to the regulatory process used to identify, measure, and
Nitrosamine Risk Assessment and Testing in ANDA Submissions: Regulatory Expectations Read More »
